587 related articles for article (PubMed ID: 12525621)
21. Drug resistance patterns of recombinant herpes simplex virus DNA polymerase mutants generated with a set of overlapping cosmids and plasmids.
Bestman-Smith J; Boivin G
J Virol; 2003 Jul; 77(14):7820-9. PubMed ID: 12829822
[TBL] [Abstract][Full Text] [Related]
22. A point mutation within conserved region VI of herpes simplex virus type 1 DNA polymerase confers altered drug sensitivity and enhances replication fidelity.
Hwang YT; Zuccola HJ; Lu Q; Hwang CB
J Virol; 2004 Jan; 78(2):650-7. PubMed ID: 14694096
[TBL] [Abstract][Full Text] [Related]
23. Herpesvirus DNA polymerases: Structures, functions and inhibitors.
Zarrouk K; Piret J; Boivin G
Virus Res; 2017 Apr; 234():177-192. PubMed ID: 28153606
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of the herpes simplex virus 1 DNA polymerase.
Liu S; Knafels JD; Chang JS; Waszak GA; Baldwin ET; Deibel MR; Thomsen DR; Homa FL; Wells PA; Tory MC; Poorman RA; Gao H; Qiu X; Seddon AP
J Biol Chem; 2006 Jun; 281(26):18193-200. PubMed ID: 16638752
[TBL] [Abstract][Full Text] [Related]
25. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.
Prichard MN; Quenelle DC; Hartline CB; Harden EA; Jefferson G; Frederick SL; Daily SL; Whitley RJ; Tiwari KN; Maddry JA; Secrist JA; Kern ER
Antimicrob Agents Chemother; 2009 Dec; 53(12):5251-8. PubMed ID: 19770274
[TBL] [Abstract][Full Text] [Related]
27. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
Marcelletti JF
Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
[TBL] [Abstract][Full Text] [Related]
28. Utility of ultra-deep sequencing for detection of varicella-zoster virus antiviral resistance mutations.
Mercier-Darty M; Boutolleau D; Lepeule R; Rodriguez C; Burrel S
Antiviral Res; 2018 Mar; 151():20-23. PubMed ID: 29337163
[TBL] [Abstract][Full Text] [Related]
29. The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
Andrei G; Gillemot S; Topalis D; Snoeck R
J Infect Dis; 2018 Feb; 217(5):790-801. PubMed ID: 29186456
[TBL] [Abstract][Full Text] [Related]
30. Resistance to a Nucleoside Analog Antiviral Drug from More Rapid Extension of Drug-Containing Primers.
Chen H; Lawler JL; Filman DJ; Hogle JM; Coen DM
mBio; 2021 Feb; 12(1):. PubMed ID: 33563814
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of HSV-1 replication and HSV DNA polymerase by the chloroxoquinolinic ribonucleoside 6-chloro-1,4-dihydro-4-oxo-1-(beta-D-ribofuranosyl) quinoline-3-carboxylic acid and its aglycone.
Souza TM; De Souza MC; Ferreira VF; Canuto CV; Marques IP; Fontes CF; Frugulhetti IC
Antiviral Res; 2008 Jan; 77(1):20-7. PubMed ID: 17931712
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene can confer altered drug sensitivities.
Hwang YT; Smith JF; Gao L; Hwang CB
Virology; 1998 Jul; 246(2):298-305. PubMed ID: 9657948
[TBL] [Abstract][Full Text] [Related]
33. Mode of action of (1'S,2'R)-9-[[1',2'-bis(hydroxymethyl) cycloprop-1'-yl]methyl]guanine (A-5021) against herpes simplex virus type 1 and type 2 and varicella-zoster virus.
Ono N; Iwayama S; Suzuki K; Sekiyama T; Nakazawa H; Tsuji T; Okunishi M; Daikoku T; Nishiyama Y
Antimicrob Agents Chemother; 1998 Aug; 42(8):2095-102. PubMed ID: 9687413
[TBL] [Abstract][Full Text] [Related]
34. Impact of Amino Acid Substitutions in Region II and Helix K of Herpes Simplex Virus 1 and Human Cytomegalovirus DNA Polymerases on Resistance to Foscarnet.
Zarrouk K; Zhu X; Pham VD; Goyette N; Piret J; Shi R; Boivin G
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0039021. PubMed ID: 33875432
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of herpes simplex virus replication by a 2-amino thiazole via interactions with the helicase component of the UL5-UL8-UL52 complex.
Spector FC; Liang L; Giordano H; Sivaraja M; Peterson MG
J Virol; 1998 Sep; 72(9):6979-87. PubMed ID: 9696789
[TBL] [Abstract][Full Text] [Related]
36. Resveratrol suppresses nuclear factor-kappaB in herpes simplex virus infected cells.
Faith SA; Sweet TJ; Bailey E; Booth T; Docherty JJ
Antiviral Res; 2006 Dec; 72(3):242-51. PubMed ID: 16876885
[TBL] [Abstract][Full Text] [Related]
37. Characterization of the DNA polymerase gene of varicella-zoster viruses resistant to acyclovir.
Kamiyama T; Kurokawa M; Shiraki K
J Gen Virol; 2001 Nov; 82(Pt 11):2761-2765. PubMed ID: 11602787
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of clinical isolates of human cytomegalovirus and varicella zoster virus by PNU-183792, a 4-oxo-dihydroquinoline.
Knechtel ML; Huang A; Vaillancourt VA; Brideau RJ
J Med Virol; 2002 Oct; 68(2):234-6. PubMed ID: 12210413
[TBL] [Abstract][Full Text] [Related]
39. Mode of action of (R)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine against herpesviruses.
Lowe DM; Alderton WK; Ellis MR; Parmar V; Miller WH; Roberts GB; Fyfe JA; Gaillard R; Ertl P; Snowden W
Antimicrob Agents Chemother; 1995 Aug; 39(8):1802-8. PubMed ID: 7486922
[TBL] [Abstract][Full Text] [Related]
40. Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.
Burrel S; Deback C; Agut H; Boutolleau D
Antimicrob Agents Chemother; 2010 Nov; 54(11):4833-42. PubMed ID: 20733037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]